Enhancing study success with advanced clinical research technologies and expert solutions for Congestive Heart Failure trials.
Congestive Heart Failure (CHF) Trial Solutions
Effective solutions for advancing Congestive Heart Failure research
At Signant Health, we understand the complexities inherent in congestive heart failure (CHF) trials. From patient-focused technology solutions to our in-house roster of clinical science experts, you can be sure your trials generate review-ready data while minimizing burdens of participation.
Despite advances in the management of congestive heart failure (CHF), morbidity and mortality remain high, emphasizing the need for continued research to develop new and improved treatments. At Signant, our global cardiovascular clinical development expertise, scientific leadership, and patient-centered solutions within Signant SmartSignals suite help sponsors and CROs capture reliable endpoint data while optimizing the participation experience.
Why Signant Health
- Capture High-Quality PRO Data
- Make Study Participation More Convenient
- Maximize Study IP Efficiency
- Support Endpoints & Monitoring with Objective Physical Activity Data
-
Capture High-Quality PRO Data
Capture High-Quality PRO Data
Signant's eCOA solution provides clinicians and patients with tools to improve the assessment experience: Electronic administration of PROs such as CaReQoL, KCCQ, and MLHQ makes it easier to complete them at home or site, and produces more reliable data. Video-assisted patient engagement features within a single patient app also help keep participants on track and adherent. -
Make Study Participation More Convenient
Make Study Participation More Convenient
CHF patients suffer from shortness of breath, fatigue, and mobility challenges that make it difficult to travel to the clinic for study visits. Signant SmartSignals Telemedicine provides a comprehensive platform to make virtual visits easy for patients and sites alike: Patients can self-schedule assessments and request "walk-in" consultations, and sites can conduct more frequent safety and monitoring check-ins. -
Maximize Study IP Efficiency
Maximize Study IP Efficiency
Take control of supply management for numerous medications and simplify randomization for multi-arm trial designs with Signant's global RTSM solution. Our agile design process will help you launch quickly and manage mid-study changes with ease. Plus, a dedicated team of biostatisticians and logistics experts experienced in CHF protocols will support your program no matter how or where you conduct trials. -
Support Endpoints & Monitoring with Objective Physical Activity Data
Support Endpoints & Monitoring with Objective Physical Activity Data
Signant SmartSignals eCOA makes it easy to capture real-time, objective physical activity data with no additional burden on patients. Seamless integration between the wrist-worn ActiGraph device and our eCOA solution enable study teams to view objective measures of physical activity alongside COA data, providing a more comprehensive understanding about how CHF symptoms and treatments impact patients' quality of life.
Comprehensive Congestive Heart Failure experience
STUDIES
PATIENTS
COUNTRIES
SITES
Explore our Congestive Heart Failure trial resources
eClinical solutions for CHF clinical trials
Ready to learn more?
Discover how Signant can support your current or upcoming CHF trials.